PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16193129

Nucleotide passivated cadmium sulfide quantum dots.

Mark Green·David Smyth-Boyle·Joanna Harries·Robin Taylor
View original source ↗Export metadata ↓

Abstract

Semiconductor quantum dots are finding numerous applications in biological systems; in this paper, we report the simple in situ preparation of nucleotide capped cadmium sulfide (CdS) nanoparticles and investigate the interaction of the capping agent with the nanoparticle surface.

Explore related subjects

Cadmium CompoundsNanoparticlesNucleotidesParticle SizeQuantum DotsSulfidesSurface PropertiesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mark Green, David Smyth-Boyle, Joanna Harries, Robin Taylor. 2005-09-02. Nucleotide passivated cadmium sulfide quantum dots.. https://doi.org/10.1039/b506618b

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Synthesis of stable luminescent microspheres by a simple method.

An easy procedure for preparing microspheres containing CdSe/CdS core-shell quantum dots (QDs) was demonstrated. The luminescent properties of this microsphere were characterized by fluorescence microscopy and fluorescence spectrophotometry. Scanning electron microscopy was also used in this study. Laser confocal microscopy was carried out to describe the distribution of QDs in the microsphere. Especially, the stability of microspheres was investigated. It was found that the getting microsphere was very stable in water and showed values for physiological conditions. The inherent stability of the spheres, as well as their photostability, allows them to be used in biological applications.

Cadmium Compounds↗
PubMed2007

Luminescent quantum dots fluorescence resonance energy transfer-based probes for enzymatic activity and enzyme inhibitors.

The paper describes the development and characterization of analytical properties of quantum dot-based probes for enzymatic activity and for screening enzyme inhibitors. The luminescent probes are based on fluorescence resonance energy transfer (FRET) between luminescent quantum dots that serve as donors and rhodamine acceptors that are immobilized to the surface of the quantum dots through peptide linkers. Peptide-coated CdSe/ZnS quantum dots were prepared using a one-step ligand exchange process in which RGDC peptide molecules replace trioctylphosphine oxide (TOPO) molecules as the capping ligands of the quantum dots. The peptide molecules were bound to the surface of the CdSe/ZnS quantum dots through the thiol group of the peptide cysteine residue. The peptide-coated quantum dots were labeled with rhodamine to form the FRET probes. The emission quantum yield of the quantum dot FRET probes was 4-fold lower than the emission quantum yield of TOPO-capped quantum dots. However, the quantum dot FRET probes were sufficiently bright to enable quantitative enzyme and enzyme inhibition assays. The probes were used first to test the enzymatic activity of trypsin in solution based on FRET signal changes of the quantum dot-based enzymatic probes in the presence of proteolytic enzymes. For example, exposure of the quantum dot FRET probes to 500 microg/mL trypsin for 15 min resulted in 60% increase in the photoluminescence of the quantum dots and a corresponding decrease in the emission of the rhodamine molecules. These changes resulted from the release of rhodamine molecules from the surface of the quantum dots due to enzymatic cleavage of the peptide molecules. The quantum dot FRET-based probes were used to monitor the enzymatic activity of trypsin and to screen trypsin inhibitors for their inhibition efficiency.

Cadmium Compounds↗